Seventh follow-up: Whole-body CT showed no signs of recurrence or metastasis. Tumor marker levels: AFP, 8.5 ng/mL; CEA, 3.9 ng/mL; CA19-9, 14.5 U/mL; CA72-4, 14.33 U/mL. This evidence concerns the gene CEACAM5 and neoplasm.